NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
Publication
, Journal Article
Mehta-Shah, N; Horwitz, SM; Ansell, S; Ai, WZ; Barnes, J; Barta, SK; Clemens, MW; Dogan, A; Fisher, K; Goodman, AM; Goyal, G; Guitart, J ...
Published in: J Natl Compr Canc Netw
May 2020
Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL), and Sézary syndrome (SS) is a rare erythrodermic and leukemic subtype of CTCL characterized by significant blood involvement. Although early-stage disease can be effectively treated predominantly with skin-directed therapies, systemic therapy is often necessary for the treatment of advanced-stage disease. Systemic therapy options have evolved in recent years with the approval of novel agents such as romidepsin, brentuximab vedotin, and mogamulizumab. These NCCN Guidelines Insights discuss the diagnosis and management of MF and SS (with a focus on systemic therapy).
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2020
Volume
18
Issue
5
Start / End Page
522 / 536
Location
United States
Related Subject Headings
- Skin Neoplasms
- Oncology & Carcinogenesis
- Mycosis Fungoides
- Lymphoma, T-Cell, Cutaneous
- Humans
- Guidelines as Topic
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Mehta-Shah, N., Horwitz, S. M., Ansell, S., Ai, W. Z., Barnes, J., Barta, S. K., … Kim, Y. H. (2020). NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. J Natl Compr Canc Netw, 18(5), 522–536. https://doi.org/10.6004/jnccn.2020.0022
Mehta-Shah, Neha, Steven M. Horwitz, Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Mark W. Clemens, et al. “NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.” J Natl Compr Canc Netw 18, no. 5 (May 2020): 522–36. https://doi.org/10.6004/jnccn.2020.0022.
Mehta-Shah N, Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, et al. NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. J Natl Compr Canc Netw. 2020 May;18(5):522–36.
Mehta-Shah, Neha, et al. “NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.” J Natl Compr Canc Netw, vol. 18, no. 5, May 2020, pp. 522–36. Pubmed, doi:10.6004/jnccn.2020.0022.
Mehta-Shah N, Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Fisher K, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Lunning MA, Mehta A, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H, Kim YH. NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. J Natl Compr Canc Netw. 2020 May;18(5):522–536.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2020
Volume
18
Issue
5
Start / End Page
522 / 536
Location
United States
Related Subject Headings
- Skin Neoplasms
- Oncology & Carcinogenesis
- Mycosis Fungoides
- Lymphoma, T-Cell, Cutaneous
- Humans
- Guidelines as Topic
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis